vs
Side-by-side financial comparison of Citi Trends Inc (CTRN) and iRhythm Holdings, Inc. (IRTC). Click either name above to swap in a different company.
iRhythm Holdings, Inc. is the larger business by last-quarter revenue ($208.9M vs $197.1M, roughly 1.1× Citi Trends Inc). iRhythm Holdings, Inc. runs the higher net margin — 2.7% vs -3.5%, a 6.2% gap on every dollar of revenue. On growth, iRhythm Holdings, Inc. posted the faster year-over-year revenue change (27.1% vs 10.1%). iRhythm Holdings, Inc. produced more free cash flow last quarter ($14.5M vs $767.0K). Over the past eight quarters, iRhythm Holdings, Inc.'s revenue compounded faster (25.8% CAGR vs -4.3%).
Citi Trends, Inc. is an American retail clothing chain selling discounted products targeted primarily at African-American customers.
iRhythm Holdings is a digital healthcare company focused on cardiac care, developing and commercializing wearable ambulatory heart monitoring devices paired with AI-powered analytical tools. It primarily serves healthcare providers and patients across the United States, helping to detect undiagnosed arrhythmias such as atrial fibrillation through convenient long-term heart rhythm tracking that delivers actionable clinical insights.
CTRN vs IRTC — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $197.1M | $208.9M |
| Net Profit | $-6.9M | $5.6M |
| Gross Margin | — | 70.9% |
| Operating Margin | -3.7% | 1.1% |
| Net Margin | -3.5% | 2.7% |
| Revenue YoY | 10.1% | 27.1% |
| Net Profit YoY | 3.6% | 518.5% |
| EPS (diluted) | $-0.86 | $0.18 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $197.1M | $208.9M | ||
| Q3 25 | $190.8M | $192.9M | ||
| Q2 25 | $201.7M | $186.7M | ||
| Q1 25 | $211.2M | $158.7M | ||
| Q4 24 | $179.1M | $164.3M | ||
| Q3 24 | $176.6M | $147.5M | ||
| Q2 24 | $186.3M | $148.0M | ||
| Q1 24 | $215.2M | $131.9M |
| Q4 25 | $-6.9M | $5.6M | ||
| Q3 25 | $3.8M | $-5.2M | ||
| Q2 25 | $871.0K | $-14.2M | ||
| Q1 25 | $-14.2M | $-30.7M | ||
| Q4 24 | $-7.2M | $-1.3M | ||
| Q3 24 | $-18.4M | $-46.2M | ||
| Q2 24 | $-3.4M | $-20.1M | ||
| Q1 24 | $3.6M | $-45.7M |
| Q4 25 | — | 70.9% | ||
| Q3 25 | — | 71.1% | ||
| Q2 25 | — | 71.2% | ||
| Q1 25 | — | 68.8% | ||
| Q4 24 | — | 70.0% | ||
| Q3 24 | — | 68.8% | ||
| Q2 24 | — | 69.9% | ||
| Q1 24 | — | 66.3% |
| Q4 25 | -3.7% | 1.1% | ||
| Q3 25 | 1.8% | -4.4% | ||
| Q2 25 | 0.2% | -10.0% | ||
| Q1 25 | 0.6% | -20.5% | ||
| Q4 24 | -4.9% | -2.5% | ||
| Q3 24 | -14.1% | -34.1% | ||
| Q2 24 | -3.7% | -15.5% | ||
| Q1 24 | 1.8% | -28.9% |
| Q4 25 | -3.5% | 2.7% | ||
| Q3 25 | 2.0% | -2.7% | ||
| Q2 25 | 0.4% | -7.6% | ||
| Q1 25 | -6.7% | -19.3% | ||
| Q4 24 | -4.0% | -0.8% | ||
| Q3 24 | -10.4% | -31.3% | ||
| Q2 24 | -1.8% | -13.6% | ||
| Q1 24 | 1.7% | -34.6% |
| Q4 25 | $-0.86 | $0.18 | ||
| Q3 25 | $0.46 | $-0.16 | ||
| Q2 25 | $0.11 | $-0.44 | ||
| Q1 25 | $-1.70 | $-0.97 | ||
| Q4 24 | $-0.86 | $-0.03 | ||
| Q3 24 | $-2.21 | $-1.48 | ||
| Q2 24 | $-0.42 | $-0.65 | ||
| Q1 24 | $0.43 | $-1.47 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $583.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $107.8M | $152.7M |
| Total Assets | $464.3M | $1.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $583.8M | ||
| Q3 25 | — | $565.2M | ||
| Q2 25 | — | $545.5M | ||
| Q1 25 | — | $520.6M | ||
| Q4 24 | — | $535.6M | ||
| Q3 24 | — | $522.0M | ||
| Q2 24 | — | $561.5M | ||
| Q1 24 | — | $569.1M |
| Q4 25 | $107.8M | $152.7M | ||
| Q3 25 | $113.2M | $121.9M | ||
| Q2 25 | $108.6M | $103.7M | ||
| Q1 25 | $113.2M | $86.7M | ||
| Q4 24 | $130.3M | $90.9M | ||
| Q3 24 | $136.6M | $71.8M | ||
| Q2 24 | $154.8M | $99.2M | ||
| Q1 24 | $157.7M | $90.3M |
| Q4 25 | $464.3M | $1.0B | ||
| Q3 25 | $457.4M | $995.2M | ||
| Q2 25 | $437.4M | $964.0M | ||
| Q1 25 | $462.8M | $926.1M | ||
| Q4 24 | $467.1M | $931.4M | ||
| Q3 24 | $506.7M | $909.7M | ||
| Q2 24 | $484.1M | $919.2M | ||
| Q1 24 | $518.7M | $909.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $8.6M | $26.2M |
| Free Cash FlowOCF − Capex | $767.0K | $14.5M |
| FCF MarginFCF / Revenue | 0.4% | 6.9% |
| Capex IntensityCapex / Revenue | 4.0% | 5.6% |
| Cash ConversionOCF / Net Profit | — | 4.70× |
| TTM Free Cash FlowTrailing 4 quarters | $11.9M | $34.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.6M | $26.2M | ||
| Q3 25 | $3.9M | $34.9M | ||
| Q2 25 | $-11.0M | $27.7M | ||
| Q1 25 | $28.5M | $-7.9M | ||
| Q4 24 | $-18.4M | $19.2M | ||
| Q3 24 | $5.6M | $24.3M | ||
| Q2 24 | $-19.6M | $11.8M | ||
| Q1 24 | $23.3M | $-52.0M |
| Q4 25 | $767.0K | $14.5M | ||
| Q3 25 | $-1.7M | $20.1M | ||
| Q2 25 | $-13.1M | $17.3M | ||
| Q1 25 | $26.0M | $-17.3M | ||
| Q4 24 | $-20.4M | $12.4M | ||
| Q3 24 | $1.7M | $15.5M | ||
| Q2 24 | $-21.2M | $3.4M | ||
| Q1 24 | $20.0M | $-61.8M |
| Q4 25 | 0.4% | 6.9% | ||
| Q3 25 | -0.9% | 10.4% | ||
| Q2 25 | -6.5% | 9.3% | ||
| Q1 25 | 12.3% | -10.9% | ||
| Q4 24 | -11.4% | 7.5% | ||
| Q3 24 | 0.9% | 10.5% | ||
| Q2 24 | -11.4% | 2.3% | ||
| Q1 24 | 9.3% | -46.8% |
| Q4 25 | 4.0% | 5.6% | ||
| Q3 25 | 2.9% | 7.7% | ||
| Q2 25 | 1.0% | 5.6% | ||
| Q1 25 | 1.2% | 5.9% | ||
| Q4 24 | 1.1% | 4.2% | ||
| Q3 24 | 2.2% | 6.0% | ||
| Q2 24 | 0.9% | 5.7% | ||
| Q1 24 | 1.5% | 7.4% |
| Q4 25 | — | 4.70× | ||
| Q3 25 | 1.01× | — | ||
| Q2 25 | -12.59× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 6.56× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTRN
Segment breakdown not available.
IRTC
| Commercial Payors | $111.7M | 53% |
| Centers For Medicare And Medicaid | $49.2M | 24% |
| Healthcare Institutions | $34.3M | 16% |
| Non Contracted Third Party Payors | $13.7M | 7% |
